BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27320335)

  • 1. Natural and Structure-based RXR Ligand Scaffolds and Their Functions.
    Dominguez M; Alvarez S; de Lera AR
    Curr Top Med Chem; 2017; 17(6):631-662. PubMed ID: 27320335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of RXR function through ligand design.
    Pérez E; Bourguet W; Gronemeyer H; de Lera AR
    Biochim Biophys Acta; 2012 Jan; 1821(1):57-69. PubMed ID: 21515403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand Design for Modulation of RXR Functions.
    Martínez C; Souto JA; de Lera AR
    Methods Mol Biol; 2019; 2019():51-72. PubMed ID: 31359388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural ligands of RXR receptors.
    García P; Lorenzo P; de Lera AR
    Methods Enzymol; 2020; 637():209-234. PubMed ID: 32359646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in drug design with RXR modulators.
    Vaz B; de Lera ÁR
    Expert Opin Drug Discov; 2012 Nov; 7(11):1003-16. PubMed ID: 22954251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoid X Receptor Selective Agonists and their Synthetic Methods.
    Wagner CE; Jurutka PW; Marshall PA; Heck MC
    Curr Top Med Chem; 2017; 17(6):742-767. PubMed ID: 27320333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a "Gatekeeper" Antagonist that Blocks Entry Pathway to Retinoid X Receptors (RXRs) without Allosteric Ligand Inhibition in Permissive RXR Heterodimers.
    Watanabe M; Fujihara M; Motoyama T; Kawasaki M; Yamada S; Takamura Y; Ito S; Makishima M; Nakano S; Kakuta H
    J Med Chem; 2021 Jan; 64(1):430-439. PubMed ID: 33356247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The retinoid X receptor and its ligands: versatile regulators of metabolic function, cell differentiation and cell death.
    Ahuja HS; Szanto A; Nagy L; Davies PJ
    J Biol Regul Homeost Agents; 2003; 17(1):29-45. PubMed ID: 12757020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural and synthetic retinoid X receptor ligands and their role in selected nuclear receptor action.
    Brtko J; Dvorak Z
    Biochimie; 2020 Dec; 179():157-168. PubMed ID: 33011201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corepressor interaction differentiates the permissive and non-permissive retinoid X receptor heterodimers.
    Lammi J; Perlmann T; Aarnisalo P
    Arch Biochem Biophys; 2008 Apr; 472(2):105-14. PubMed ID: 18282463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods to Assess Activity and Potency of Rexinoids Using Rapid Luciferase-Based Assays: A Case Study with NEt-TMN.
    Jurutka PW; Wagner CE
    Methods Mol Biol; 2019; 2019():95-108. PubMed ID: 31359391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A naturally occurring rexinoid, honokiol, can serve as a regulator of various retinoid x receptor heterodimers.
    Kotani H; Tanabe H; Mizukami H; Amagaya S; Inoue M
    Biol Pharm Bull; 2012; 35(1):1-9. PubMed ID: 22223330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists.
    Mukherjee R; Davies PJ; Crombie DL; Bischoff ED; Cesario RM; Jow L; Hamann LG; Boehm MF; Mondon CE; Nadzan AM; Paterniti JR; Heyman RA
    Nature; 1997 Mar; 386(6623):407-10. PubMed ID: 9121558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective ligand activity at Nur/retinoid X receptor complexes revealed by dimer-specific bioluminescence resonance energy transfer-based sensors.
    Giner XC; Cotnoir-White D; Mader S; Lévesque D
    FASEB J; 2015 Oct; 29(10):4256-67. PubMed ID: 26148973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods to Generate an Array of Novel Rexinoids by SAR on a Potent Retinoid X Receptor Agonist: A Case Study with NEt-TMN.
    Wagner CE; Jurutka PW
    Methods Mol Biol; 2019; 2019():109-121. PubMed ID: 31359392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoid X receptor ligands: a patent review (2007 - 2013).
    Yamada S; Kakuta H
    Expert Opin Ther Pat; 2014 Apr; 24(4):443-52. PubMed ID: 24456080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Isochroman Analog of CD3254 and Allyl-, Isochroman-Analogs of NEt-TMN Prove to Be More Potent Retinoid-X-Receptor (RXR) Selective Agonists Than Bexarotene.
    Jurutka PW; di Martino O; Reshi S; Mallick S; Sausedo MA; Moen GA; Lee IJ; Ivan DJ; Krall TD; Peoples SJ; Perez A; Tromba L; Le A; Khadka I; Petros R; Savage BM; Salama E; Salama J; Ziller JW; Noh Y; Lee MY; Liu W; Welch JS; Marshall PA; Wagner CE
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rexinoids isolated from Sophora tonkinensis with a gene expression profile distinct from the synthetic rexinoid bexarotene.
    Inoue M; Tanabe H; Nakashima K; Ishida Y; Kotani H
    J Nat Prod; 2014 Jul; 77(7):1670-7. PubMed ID: 24959987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating Novel RXR Agonists That Induce ApoE and Tyrosine Hydroxylase in Cultured Human Glioblastoma Cells.
    Mallick S; Marshall PA; Wagner CE; Heck MC; Sabir ZL; Sabir MS; Dussik CM; Grozic A; Kaneko I; Jurutka PW
    ACS Chem Neurosci; 2021 Mar; 12(5):857-871. PubMed ID: 33570383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterodimer formation by retinoid X receptor: regulation by ligands and by the receptor's self-association properties.
    Dong D; Noy N
    Biochemistry; 1998 Jul; 37(30):10691-700. PubMed ID: 9692959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.